New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
04:55 EDTSI, SI, SI, THOR, THOR, THOR, STJ, STJ, STJ, ATRC, ATRC, ATRC, CADX, CADX, CADX, COV, COV, COV, CRY, CRY, CRY, EW, EW, EW, HTWR, HTWR, HTWR, ISRG, ISRG, ISRG, MDT, MDT, MDT, MYGN, MYGN, MYGN, RTIX, RTIX, RTIX, WTKWY, WTKWY, WTKWYAmerican Association for Thoracic Surgery to hold annual meeting
94th Annual Meeting of AATS is being held in Toronto on April 26-30.
News For SI;RTIX;MYGN;MDT;ISRG;HTWR;EW;CRY;COV;CADX;ATRC;STJ;THOR;WTKWY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 13, 2014
07:25 EDTTHOR, COV, CRY, STJ, RTIX, HTWREuropean Association of Cardiothoracic Surgery to hold annual meeting
28th EACTS Annual Meeting is being held in Milan, Italy on October 11-15.
07:13 EDTMDT, RTIXBioFlorida to hold a conference
Subscribe for More Information
October 10, 2014
07:16 EDTRTIX, WTKWY, COVAmerican Society of Plastic Surgeons to hold annual meeting
Annual Meeting of ASPS is being held in Chicago on October 10-14.
07:04 EDTCOV, MDTMedtronic announces Omar Ishrak will remain CEO of new company
Subscribe for More Information
October 9, 2014
16:37 EDTCOVCovidien receives FDA 510k clearance for Nellcor Portable SpO2 system
Covidien announced FDA 510k clearance for the Nellcor Portable SpO2 Patient Monitoring System. The system is the only commercially available portable oximeter that is equipped with home care and sleep study modes and complies with IEC 60601-1-11 standards for devices used in the home health care environment.
16:04 EDTATRCAtriCure completes enrollment in post approval study for Synergy Ablation system
AtriCure announced enrollment in the ABLATE Post Approval Study, or PAS, is complete. As of October 3, the ABLATE PAS enrolled 365 patients at 40 hospitals across the U.S. AtriCure expects to release preliminary data from the study in about a year, with a complete report expected to be published in three years.
14:54 EDTMYGNCapital World Investors reports 10.5% passive stake in Myriad Genetics
13:46 EDTRTIXRTI Surgical receives letter from FDA on map3 cellular allogenic bone graft
Subscribe for More Information
October 8, 2014
16:09 EDTMYGNMyriad Genetics appoints former LabCorp executive Riggsbee as CFO
Myriad Genetics (MYGN) announced the appointment of R. Bryan Riggsbee as executive vice president, CFO, and Treasurer effective October 16. Jim Evans will continue in his role as CFO through the transition to Riggsbee, the company stated. Riggsbee most recently served as the senior vice president, Corporate Finance at Laboratory Corporation of America (LH).
10:46 EDTCOVOptions with decreasing implied volatility
Subscribe for More Information
October 7, 2014
10:43 EDTCOVOptions with decreasing implied volatility
Subscribe for More Information
October 6, 2014
11:25 EDTISRGIntuitive Surgical volatility increases on rally after Goldman upgrades
Subscribe for More Information
11:17 EDTISRGIntuitive Surgical climbs after Goldman ups to Buy
Subscribe for More Information
11:00 EDTCOVOptions with decreasing implied volatilit
Subscribe for More Information
10:41 EDTISRGIntuitive Surgical rises, levels to watch
At time of writing the shares were up over 3.9% to $493.83, well down from the session high at $505.74 which is resistance. At current price support is at the session low at $489.32, the opening price of the day. Goldman earlier upgraded the shares to a Buy, with a $584 price target.
10:04 EDTISRGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:56 EDTEWEdwards Lifesciences consensus estimates 'far too low,' says Leerink
Subscribe for More Information
07:26 EDTEWEdwards Lifesciences target raised to $121-$122 from $94-$95 at Wells Fargo
Subscribe for More Information
07:12 EDTCOVThe MedTech Conference holds a conference
AdvaMed 2014 is being held in Chicago on October 6-8.
05:22 EDTISRGIntuitive Surgical upgraded to Buy from Neutral at Goldman
Goldman Sachs upgraded Intuitive Surgical (ISRG) to Buy citing an improving hospital spending environment and long-term uptake of surgery procedures in the U.S. The firm raised its price target for shares to $584 from $466. Shares of the robotic surgery maker closed Friday at $475.21.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use